DK0788491T3 - 6-Polyfluoralkoxy- og 6-polyfluoralkyl-2-aminobenzothiazol-derivater - Google Patents

6-Polyfluoralkoxy- og 6-polyfluoralkyl-2-aminobenzothiazol-derivater

Info

Publication number
DK0788491T3
DK0788491T3 DK95935997T DK95935997T DK0788491T3 DK 0788491 T3 DK0788491 T3 DK 0788491T3 DK 95935997 T DK95935997 T DK 95935997T DK 95935997 T DK95935997 T DK 95935997T DK 0788491 T3 DK0788491 T3 DK 0788491T3
Authority
DK
Denmark
Prior art keywords
pct
polyfluoroalkoxy
polyfluoroalkyl
sec
date
Prior art date
Application number
DK95935997T
Other languages
English (en)
Inventor
Philip Chapelle
Claude Gaillard
Patrick Jimonet
Erik Louvel
Michel Martinet
Serge Mignani
Gerard Sanderink
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Application granted granted Critical
Publication of DK0788491T3 publication Critical patent/DK0788491T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Steroid Compounds (AREA)
DK95935997T 1994-10-26 1995-10-23 6-Polyfluoralkoxy- og 6-polyfluoralkyl-2-aminobenzothiazol-derivater DK0788491T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9412796A FR2726271B1 (fr) 1994-10-26 1994-10-26 Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole
PCT/FR1995/001392 WO1996013492A1 (fr) 1994-10-26 1995-10-23 Derives de 6-polyfluoroalcoxy et 6-polyfluoroalkyle-2-aminobenzothiazole

Publications (1)

Publication Number Publication Date
DK0788491T3 true DK0788491T3 (da) 2000-05-08

Family

ID=9468224

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95935997T DK0788491T3 (da) 1994-10-26 1995-10-23 6-Polyfluoralkoxy- og 6-polyfluoralkyl-2-aminobenzothiazol-derivater

Country Status (12)

Country Link
US (1) US5795903A (da)
EP (1) EP0788491B1 (da)
JP (1) JP3882198B2 (da)
AT (1) ATE187169T1 (da)
AU (1) AU3809095A (da)
DE (1) DE69513679T2 (da)
DK (1) DK0788491T3 (da)
ES (1) ES2139247T3 (da)
FR (1) FR2726271B1 (da)
GR (1) GR3032022T3 (da)
WO (1) WO1996013492A1 (da)
ZA (1) ZA958861B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
PL332413A1 (en) 1996-09-27 1999-09-13 Guilford Pharm Inc Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals
FR2774592B1 (fr) * 1998-02-06 2000-03-17 Rhone Poulenc Rorer Sa Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet
EP1416931B1 (en) * 2001-08-13 2007-06-13 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibitors of polyq-aggregation
WO2004098494A2 (en) * 2003-04-30 2004-11-18 Cytokinetics, Inc. Compounds, compositions, and methods
US8710088B2 (en) * 2004-02-11 2014-04-29 Max-Delbruck-Centrum Fur Molekulare Medizin Pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
CN110709386B (zh) 2017-03-30 2022-06-07 凯瑞康宁生物工程（武汉）有限公司 双环杂芳基衍生物及其制备与用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492258A1 (fr) * 1980-10-17 1982-04-23 Pharmindustrie Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
FR2649701B2 (fr) * 1988-12-15 1991-11-22 Rhone Poulenc Sante Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
EP0374041B1 (fr) * 1988-12-15 1992-06-17 Rhone-Poulenc Sante Médicaments à base de dérivés de la benzothiazolamine-2, dérivés et leur préparation
US5236940A (en) * 1988-12-15 1993-08-17 Rhone-Poulenc Sante Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation

Also Published As

Publication number Publication date
FR2726271B1 (fr) 1996-12-06
WO1996013492A1 (fr) 1996-05-09
EP0788491B1 (fr) 1999-12-01
EP0788491A1 (fr) 1997-08-13
FR2726271A1 (fr) 1996-05-03
GR3032022T3 (en) 2000-03-31
DE69513679T2 (de) 2000-06-21
ES2139247T3 (es) 2000-02-01
AU3809095A (en) 1996-05-23
US5795903A (en) 1998-08-18
ZA958861B (en) 1996-05-09
ATE187169T1 (de) 1999-12-15
JPH10508014A (ja) 1998-08-04
JP3882198B2 (ja) 2007-02-14
DE69513679D1 (de) 2000-01-05

Similar Documents

Publication Publication Date Title
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
AU2936195A (en) Cyclic amide derivatives for protecting against ultraviolet rays
PT91574A (pt) Procede de preparation de n-cycloalkyle benzyamines utiles comme medicaments
DK0788491T3 (da) 6-Polyfluoralkoxy- og 6-polyfluoralkyl-2-aminobenzothiazol-derivater
IT1196423B (it) Benzotiazolin-composti
AU2961784A (en) Pyridazinones their preparation and use and medicaments containing pyridazinones
HUT77768A (hu) N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
AU7899891A (en) Compounds for the treatment of age-related memory impairment and other cognitive disorders
MX9101948A (es) Composicion farmaceutica que contiene derivados de tiazoloisoindolinona
ATE181734T1 (de) N-benzoylmethylsubstituierte paroxetinderivate
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
DK0641346T3 (da) Antibiotiske 7-aminonaphthazarinderivater
DE69131353D1 (de) Indolderivate
DE69312512D1 (de) Etoposid-derivate, ihre herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
ATE205853T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
EP1123704A4 (en) Remedies for spinal canal stenosis
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application
DK0614457T3 (da)
FR2695643B1 (fr) Dérivés d'uréido-acétamide, leur préparation et les médicaments les contenant.
ES2088320T3 (es) Derivados de carboestirilo.